IPSC Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly as Pipeline Advances XOMAO Q1 2026 Earnings Preferred Stock Reports Negative EPS Surprise Amid Quiet Quarter Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses MCS Q1 2026 Earnings NarrowerThanExpected Loss Offers Modest Relief Calavo Growers Q1 2026 Earnings EPS Beats Estimates by 23 Amid Operational Improvements APAM Q1 2026 Earnings EPS Misses Consensus as Market Headwinds Persist